Mechanism of Sorafenib Resistance in Patients With Advanced Hepatocellular Carcinoma

Clinical trial NCT02733809 · UNKNOWN

Trial details

NCT number: NCT02733809
Sponsor: King Saud University
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2014-01-01
Primary completion: 2024-12-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.